Continued Low Efficacy of Artemether-Lumefantrine in Angola?
作者信息
Rasmussen Charlotte, Ringwald Pascal
机构信息
Global Malaria Programme, World Health Organization, Geneva, Switzerland
Global Malaria Programme, World Health Organization, Geneva, Switzerland.
出版信息
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.00220-21.
Abstract
摘要
相似文献
1
Continued Low Efficacy of Artemether-Lumefantrine in Angola?
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.00220-21.
2
Reply to Rasmussen and Ringwald, "Continued Low Efficacy of Artemether-Lumefantrine in Angola?".
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.00338-21.
3
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Malar J. 2018 Apr 3;17(1):144. doi: 10.1186/s12936-018-2290-9.
4
Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique.
Int J Infect Dis. 2021 Sep;110:151-154. doi: 10.1016/j.ijid.2021.07.008. Epub 2021 Jul 7.
5
Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019.
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01949-20.
6
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
Antimicrob Agents Chemother. 2015 Jan;59(1):437-43. doi: 10.1128/AAC.04181-14. Epub 2014 Nov 3.
7
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.
Malar J. 2018 Feb 20;17(1):84. doi: 10.1186/s12936-018-2233-5.
8
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
Malar J. 2017 Feb 2;16(1):62. doi: 10.1186/s12936-017-1712-4.
9
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
Lancet. 2020 Apr 25;395(10233):1345-1360. doi: 10.1016/S0140-6736(20)30552-3. Epub 2020 Mar 11.
10
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01140-19.
引用本文的文献
1
Emerging Plasmodium falciparum K13 gene mutation to artemisinin-based combination therapies and partner drugs among malaria-infected population in sub-Saharan Africa.
Parasites Hosts Dis. 2025 May;63(2):109-122. doi: 10.3347/PHD.24053. Epub 2025 May 26.
2
drug susceptibility and resistance mediating genetic polymorphisms of in Bobo-Dioulasso, Burkina Faso.
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0153423. doi: 10.1128/aac.01534-23. Epub 2024 Feb 27.
3
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa.
Nat Rev Microbiol. 2024 Jun;22(6):373-384. doi: 10.1038/s41579-024-01008-2. Epub 2024 Feb 6.
4
A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria.
Malar J. 2023 Jun 17;22(1):185. doi: 10.1186/s12936-023-04622-2.
5
Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.
PLoS One. 2022 Sep 9;17(9):e0273249. doi: 10.1371/journal.pone.0273249. eCollection 2022.
6
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.
Int J Parasitol Drugs Drug Resist. 2021 Aug;16:102-118. doi: 10.1016/j.ijpddr.2021.05.007. Epub 2021 May 26.
7
Reply to Rasmussen and Ringwald, "Continued Low Efficacy of Artemether-Lumefantrine in Angola?".
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.00338-21.
本文引用的文献
1
Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019.
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01949-20.
2
A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy.
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01517-19.
3
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.
BMC Med. 2015 Sep 18;13:227. doi: 10.1186/s12916-015-0456-7.
4
Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping.
Antimicrob Agents Chemother. 2015 Oct;59(10):6096-100. doi: 10.1128/AAC.00072-15. Epub 2015 Jul 20.
5
Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether.
Mem Inst Oswaldo Cruz. 2013 Dec;108(8):968-73. doi: 10.1590/0074-0276130167.
Zotero 插件